InspireMD, Inc. (NSPR)
NSPR Stock Price Chart
Explore InspireMD, Inc. interactive price chart. Choose custom timeframes to analyze NSPR price movements and trends.
NSPR Company Profile
Discover essential business fundamentals and corporate details for InspireMD, Inc. (NSPR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Apr 2011
Employees
85.00
Website
https://www.inspiremd.comCEO
Marvin L. Slosman
Description
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
NSPR Financial Timeline
Browse a chronological timeline of InspireMD, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Aug 2026
EPS estimate is -$0.20, while revenue estimate is $1.38m.
Earnings released on 4 May 2026
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $3.40m , beating expectations by +25.77%.
Earnings released on 18 Mar 2026
EPS came in at -$0.14 surpassing the estimated -$0.22 by +36.36%, while revenue for the quarter reached $3.15m , beating expectations by +19.89%.
Earnings released on 4 Nov 2025
EPS came in at -$0.17 matching the estimated -$0.17, while revenue for the quarter reached $2.52m , missing expectations by -3.95%.
Earnings released on 4 Aug 2025
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%, while revenue for the quarter reached $1.78m , beating expectations by +1.05%.
Earnings released on 9 May 2025
EPS came in at -$0.22 falling short of the estimated -$0.17 by -29.41%, while revenue for the quarter reached $1.53m , beating expectations by +1.93%.
Earnings released on 12 Mar 2025
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%, while revenue for the quarter reached $1.95m , beating expectations by +34.23%.
Earnings released on 12 Nov 2024
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%, while revenue for the quarter reached $1.81m , missing expectations by -1.25%.
Earnings released on 6 Aug 2024
EPS came in at -$0.22 falling short of the estimated -$0.19 by -15.79%, while revenue for the quarter reached $1.74m , missing expectations by -0.06%.
Earnings released on 14 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.15 by -40.00%, while revenue for the quarter reached $1.51m , beating expectations by +9.49%.
Earnings released on 6 Mar 2024
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%, while revenue for the quarter reached $1.76m , beating expectations by +14.35%.
Earnings released on 6 Nov 2023
EPS came in at -$0.15 surpassing the estimated -$0.17 by +11.76%, while revenue for the quarter reached $1.56m , missing expectations by -4.54%.
Earnings released on 8 Aug 2023
EPS came in at -$0.24 falling short of the estimated -$0.17 by -41.18%, while revenue for the quarter reached $1.65m , beating expectations by +6.39%.
Earnings released on 15 May 2023
EPS came in at -$0.53 surpassing the estimated -$0.68 by +22.06%, while revenue for the quarter reached $1.24m , beating expectations by +23.90%.
Earnings released on 30 Mar 2023
EPS came in at -$0.60 falling short of the estimated $0.84 by -171.43%, while revenue for the quarter reached $1.03m , beating expectations by +2.60%.
Earnings released on 8 Nov 2022
EPS came in at -$0.58 surpassing the estimated -$0.73 by +20.55%, while revenue for the quarter reached $1.43m , beating expectations by +2.21%.
Earnings released on 9 Aug 2022
EPS came in at -$0.59 surpassing the estimated -$0.73 by +19.18%, while revenue for the quarter reached $1.53m , beating expectations by +27.58%.
Earnings released on 10 May 2022
EPS came in at -$0.57 surpassing the estimated -$0.80 by +28.75%, while revenue for the quarter reached $1.18m , missing expectations by -15.50%.
Earnings released on 8 Mar 2022
EPS came in at -$0.53 surpassing the estimated -$0.78 by +32.05%, while revenue for the quarter reached $1.38m , beating expectations by +6.15%.
Earnings released on 9 Nov 2021
EPS came in at -$0.53 , while revenue for the quarter reached $1.07m , missing expectations by -10.75%.
Earnings released on 10 Aug 2021
EPS came in at -$0.46 , while revenue for the quarter reached $1.04m , missing expectations by -5.64%.
NSPR Stock Performance
Access detailed NSPR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
